FDA Approved: LAMOTRIGINE — Supplemental Application (Endo USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Lamotrigine (generic) from Endo USA, Inc. under ANDA 204158, authorizing its marketing in the United States. Lamotri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Epilepsy

Drugs mentioned

• Lamotrigine (lamotrigine)

Snippet

SUPPL AP for LAMOTRIGINE (LAMOTRIGINE)